In a research report issued today, Roth Capital analyst Chris Lewis maintained a Buy rating on EnteroMedics Inc (NASDAQ:ETRM) with a $3 price target, as …
Before the market opened Tuesday, Roth Capital analyst Chris Lewis reiterated a Buy rating on Enteromedics (NASDAQ:ETRM) with a $3 price target, which represents …
In a research report issued a short while ago, Canaccord Genuity analyst William Plovanic maintained a Buy rating on Enteromedics (NASDAQ:ETRM) with a …
